Table 2.
Cytoplasmic ARS | |
---|---|
AARS | epileptic encephalopathy with persistent myelination defect (MIM: 616339)26 |
DARS | hypomyelinating leukodystrophy with brainstem involvement and leg spasticity (MIM: 615281)7 |
EPRS | hypomyelinating leukodystrophy |
GARS | Charcot-Marie tooth disease (CMT) type 2D (MIM 601472), distal hereditary motor neuropathy 5A (MIM: 600794)27 |
HARS | CMT type 2W (MIM: 616625)28 |
KARS | AR deafness 89, recessive intermediate B (MIM: 613916),28 and Charcot Marie Tooth (CMT) Disease Type 2 (MIM: 613641)29 |
MARS | late-onset CMT type 2U (MIM: 616280)30 |
QARS | progressive microcephaly, intractable seizures and cerebral and cerebellar atrophy (MIM: 615760)31 |
RARS | hypomyelinating leukodystrophy6 (MIM: 616140) |
YARS | CMT dominant intermediate C (MIM: 6088323)32 |
Mitochondrial ARS | |
AARS2 | (ovario) leukodystrophy and combined oxidative phosphorylation deficiency (MIM: 615889)33 |
DARS2 | leukoencephalopathy with brain stem and spinal cord involvement and lactate elevation (MIM: 611105)34 |
EARS2 | leukoencephalopathy with thalamus and brainstem involvement with high lactate (MIM: 614924)35 |
FARS2 | alpers encephalopathy (MIM: 614946)36 |
HARS2 | perrault syndrome (MIM: 614926)37 |
MARS2 | autosomal recessive spastic ataxia with leukoencephalopathy (MIM: 611390)38 |
RARS2 | pontocerebellar hypoplasia type 6 (MIM: 611523)39 |
TARS2 | mitochondrial encephalopathy (combined oxidative phosphorylation deficiency 21) (MIM: 615918)40 |
VARS2 | mitochondrial encephalopathy (combined oxidative phosphorylation deficiency 20) (MIM: 615917)40 |
tRNA Synthetase Cofactor Gene | |
AIMP1 | hypomyelination secondary to neuronal disorder (MIM: 260600)25 |
AIMP2 | hypomyelination secondary to neuronal disorder41 |
Underlined genes are the genes associated with hypomyelination.